List of works - Claudio R Gimpelewicz

Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial

scientific article published on 25 September 2017

Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2

scientific article published on 10 November 2020

Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic Cardiomyopathy

scientific article published in November 2017

Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial

scientific article published on 22 February 2017

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

article

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

scientific article published on 02 September 2013

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

scientific article published on March 2013

Effects of Serelaxin in Patients with Acute Heart Failure

scientific article published on 01 August 2019

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial

scientific article published on 27 May 2017

Hepatorenal dysfunction identifies high-risk patients with acute heart failure: insights from the RELAX-AHF trial

scientific article published on 30 September 2019

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment

scientific article published on 27 March 2017

Rationale and design of the multicentre, randomized, double‐blind, placebo‐controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) ⬇️

scientific article published on November 30, 2010

Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX-AHF-2 trial

scientific article published on 05 March 2020

Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study

scientific article

Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF.